Glecaprevir (Mavyret Spl 01)
Mavyret Tablet, Film Coated
Product Images NDC 0074-2625
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Mavyret (NDC 0074-2625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Pibrentasvir (Mavyret Spl 02)
Instructions For Use (Mavyret Spl 03)
Instructions For Use (Mavyret Spl 04)
Principal Display Panelndc 0074-2625-28rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mgthis Carton Contains 21 Tablets Packaged As Follows:7 Wallets For 1 Week Of Treatment. Each Wallet Contains 3 Tablets.do Not Use If Seal On Top Of Carton Is Broken Or Missingkeep Out Of Reach Of Childrenstore At Or Below 30°c (86°f)see Package Insert For Full Prescribing Informationabbvie Inc.north Chicago, Il 60064©2020 Abbvie Inc.abbvie (Mavyret Spl 05)
Principal Display Panelndc 0074-2625-01rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mgplease See Accompanying Full Prescribing Informationeach Box Contains: 1 Wallet Of 3 Tablets Eachkeep Out Of Reach Of Childrenstore At Or Below 30°c (86°f)see Package Insert For Full Prescribing Informationabbvie Inc.north Chicago, Il 60064product Of Ireland©2020 Abbvie Inc.abbvie (Mavyret Spl 06)
Principal Display Panelndc 0074-2625-28rx Only4-week Supplymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg (Mavyret Spl 07)
Principal Display Panelndc 0074-2625-80rx Onlymavyret®glecaprevir/pibrentasvir Tablets100 mg/40 mg For Institutional Use Only84 Tabletsabbviedo Not Accept If Seal Over Bottle Opening Is Broken Or Missing.each Tablet Contains Glecaprevir And Pibrentasvir 100 mg/40 mg.store At Or Below 30°c (86°f).see Package Insert For Full Prescribing Information.abbvie Inc.north Chicago, Il 60064 Usasee Opposite Side Of Label For Customs Country Of Origin.©2020 Abbvie Inc. (Mavyret Spl 08)
This is a medication description for MAVYRET, a product of Abbvie. It is available in 84 tablets and for institutional use only. Each tablet contains 100mg of glecaprevir and 40mg of pibrentasvir and should be stored below 30°C. The package insert should be referenced for full dosing and prescribing information. Additionally, the seal over the bottle opening should not be accepted if it is broken or missing.*
Principal Display Panelndc 0074-2625-28rx Onlymavyret®(glecaprevir/pibrentasivir) Oral Pellets50 mg/20 mgeach Packet Contains Pink And Yellow Oral Pellets.keep Out Of Reach Of Children.store At Or Below 30°c (86°f). Recommended Dosage: See Prescribing Information.abbvie Inc.north Chicago, Il 60044see Side Of Carton For Customs Country Of Origin.©2021 Abbvie Inc.abbvie (Mavyret Spl 09)
Principal Display Panelndc 0074-2625-84rx Onlymavyret®glecaprevir/pibrentasvir Tablets100 mg/40 mg84 Tabletsdo Not Accept If Seal Over Bottle Opening Is Broken Or Missing.each Tablet Contains Glecaprevir And Pibrentasvir 100 mg / 40 mg.store At Or Below 30°c (86°f).see Package Insert For Full Dosing And Prescribing Information.see Bottom Of Carton For Customs Country Of Origin.abbvie Inc.north Chicago, Il 60064 Usa©2020 Abbvie Inc.abbvie (Mavyret Spl 0a)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
